Clinical Trial Update: A Study of TLC590 for Postsurgical Pain Following Bunionectomy [Phase 3]

View source ↗

Summary

This entry reports a Phase 3 clinical trial evaluating TLC590 for postsurgical pain after bunionectomy, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hallux Valgus
• Postoperative Pain

Drugs mentioned

• TLC590

Snippet

Sponsor: TLC Biopharmaceuticals, Inc. | Conditions: Postoperative Pain | Phase 3 | Status: RECRUITING